600211.SS Stock Analysis
60
Attractive
Based on Eyestock quantitative analysis, 600211.SS`s fundamental data and valuation indicate an investment grade of Attractive at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
High score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly undervalued
Tibet Rhodiola Pharmaceutical Holding Co. engages in the manufacture and wholesale of pharmaceutical products. The company is headquartered in Lhasa, Xizang and currently employs 733 full-time employees. The firm operates its businesses through the distribution of proprietary drug products, as well as the processing of pharmaceuticals and others. The firm conducts its businesses primarily in South China, North China, East China, Central China and overseas markets.